Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1995 Sep;57(3):661–666.

Prenatal diagnosis of 45,X/46,XX mosaicism and 45,X: implications for postnatal outcome.

D D Koeberl 1, B McGillivray 1, V P Sybert 1
PMCID: PMC1801266  PMID: 7668295

Abstract

The prognosis for 45,X/46,XX mosaicism diagnosed prenatally has yet to be established. We report our experience with 12 patients in whom prenatal diagnosis of 45,X/46,XX mosaicism was detected by amniocentesis for advanced maternal age or decreased maternal serum alpha-feto protein and compared them with 41 45,X/46,XX patients diagnosed postnatally. The girls in the prenatal group range in age from 3 mo to 10 years. All have had normal linear growth. Four had structural anomalies including: ASD (n = 1); ptosis and esotropia (n = 1); labial fusion (n = 1); and urogenital sinus, dysplastic kidneys, and hydrometrocolpos (n = 1). Gonadotropins were measured in seven; one had elevated luteinizing hormone/FSH at 3 mo of age. One has developmental delay and seizures as well as ophthalmologic abnormalities. None would have warranted karyotyping for clinical suspicion of Turner syndrome. The prevalence of 45,X/46,XX mosaicism is 10-fold higher among amniocenteses than in series of postnatally diagnosed individuals with Turner syndrome, which suggests that most individuals with this karyotype escape detection and that an ascertainment bias exists toward those with clinically evident abnormalities. The phenomenon of a milder phenotype for the prenatal group is similar to that observed for 45,X/46,XY diagnosed prenatally. Prenatal counseling for 45,X/46,XX in the absence of such ultrasound abnormalities as hydrops fetalis should take into account the expectation of a milder phenotype (except, possibly, with respect to developmental delay) than that of patients ascertained postnatally. The same does not hold true for 45,x diagnosed prenatally.

Full text

PDF
661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang H. J., Clark R. D., Bachman H. The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases. Am J Hum Genet. 1990 Jan;46(1):156–167. [PMC free article] [PubMed] [Google Scholar]
  2. Conte F. A., Grumbach M. M., Kaplan S. L., Reiter E. O. Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. J Clin Endocrinol Metab. 1980 Jan;50(1):163–168. doi: 10.1210/jcem-50-1-163. [DOI] [PubMed] [Google Scholar]
  3. Hamill P. V., Drizd T. A., Johnson C. L., Reed R. B., Roche A. F., Moore W. M. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979 Mar;32(3):607–629. doi: 10.1093/ajcn/32.3.607. [DOI] [PubMed] [Google Scholar]
  4. Hook E. B., Warburton D. The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum Genet. 1983;64(1):24–27. doi: 10.1007/BF00289473. [DOI] [PubMed] [Google Scholar]
  5. Hsu L. Y. Prenatal diagnosis of 45,X/46,XY mosaicism--a review and update. Prenat Diagn. 1989 Jan;9(1):31–48. doi: 10.1002/pd.1970090106. [DOI] [PubMed] [Google Scholar]
  6. Kulkarni R., Hawkins J., Bradford W. P. Prenatal diagnosis of 45,X/46,XX mosaicism in the fetus. Should the pregnancy be terminated? Prenat Diagn. 1989 Jun;9(6):439–441. doi: 10.1002/pd.1970090610. [DOI] [PubMed] [Google Scholar]
  7. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am. 1991 Mar;20(1):121–152. [PubMed] [Google Scholar]
  8. Warburton D., Kline J., Stein Z., Susser M. Monosomy X: a chromosomal anomaly associated with young maternal age. Lancet. 1980 Jan 26;1(8161):167–169. doi: 10.1016/s0140-6736(80)90658-3. [DOI] [PubMed] [Google Scholar]
  9. Wheeler M., Peakman D., Robinson A., Henry G. 45,X/46,XY mosaicism: contrast of prenatal and postnatal diagnosis. Am J Med Genet. 1988 Mar;29(3):565–571. doi: 10.1002/ajmg.1320290314. [DOI] [PubMed] [Google Scholar]
  10. Wilson M. G., Lin M. S., Fujimoto A., Herbert W., Kaplan F. M. Chromosome mosaicism in 6,000 amniocenteses. Am J Med Genet. 1989 Apr;32(4):506–513. doi: 10.1002/ajmg.1320320417. [DOI] [PubMed] [Google Scholar]
  11. Winter J. S., Faiman C., Hobson W. C., Prasad A. V., Reyes F. I. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J Clin Endocrinol Metab. 1975 Apr;40(4):545–551. doi: 10.1210/jcem-40-4-545. [DOI] [PubMed] [Google Scholar]
  12. Winter J. S., Faiman C. Serum gonadotropin in concentrations in agonadal children and adults. J Clin Endocrinol Metab. 1972 Oct;35(4):561–564. doi: 10.1210/jcem-35-4-561. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES